Korro Bio is trading 5.52% higher at $16.72 in pre-market on November 3; no fresh company-specific announcement or filing was identified.
- The latest listed press release is dated October 16.
- The October 22 preclinical KRRO-111 update is prior news, not a confirmed explanation for this morning’s move.
- Supplied market indicators are mixed and do not establish a broad-market cause.